Hold an Afternoon Tea This August, drink tea, eat cake, play games, and more to help fund our research and support.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 207 results We welcome approval of palbociclib with fulvestrant for routine use on the NHS 23 Sept 2022 1 min read Fantastic outcome for certain patients with incurable secondary triple negative breast cancer as pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) is approved for use on the NHS in Scotland 10 Oct 2022 1 min read Breast Cancer Now responds to latest NHSE Cancer Wait Times data, calling for the FDS to be raised to 95% 13 Oct 2022 1 min read Breast Cancer Now responds to NICE provisional decision not to recommend pembrolizumab (Keytruda) in combination with chemotherapy (paclitaxel or nab-paclitaxel) 08 Mar 2022 3 min read We respond to NHS England breast cancer waiting times: January 2022 10 Mar 2022 1 min read We respond to NHS England's proposed new standards 09 Mar 2022 1 min read We respond to new data from major trial OlympiA shows adjuvant olaparib improved survival in patients 16 Mar 2022 1 min read We respond to research about artificial sweeteners and breast cancer risk 24 Mar 2022 1 min read We respond to NICE provisional decision not to recommend alpelisib with fulvestrant for routine use on the NHS 01 Apr 2022 1 min read We respond to new research into how salt in tumours could help diagnose and treat breast cancer 25 Apr 2022 1 min read We support latest Emmerdale storyline on Faith Dingle's Secondary Breast Cancer diagnosis 17 May 2022 1 min read We comment on saliva samples used to determine breast cancer risk in women of screening age 23 May 2022 1 min read Previous 1 ... 11 ... 18 Next
We welcome approval of palbociclib with fulvestrant for routine use on the NHS 23 Sept 2022 1 min read
Fantastic outcome for certain patients with incurable secondary triple negative breast cancer as pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) is approved for use on the NHS in Scotland 10 Oct 2022 1 min read
Breast Cancer Now responds to latest NHSE Cancer Wait Times data, calling for the FDS to be raised to 95% 13 Oct 2022 1 min read
Breast Cancer Now responds to NICE provisional decision not to recommend pembrolizumab (Keytruda) in combination with chemotherapy (paclitaxel or nab-paclitaxel) 08 Mar 2022 3 min read
We respond to new data from major trial OlympiA shows adjuvant olaparib improved survival in patients 16 Mar 2022 1 min read
We respond to NICE provisional decision not to recommend alpelisib with fulvestrant for routine use on the NHS 01 Apr 2022 1 min read
We respond to new research into how salt in tumours could help diagnose and treat breast cancer 25 Apr 2022 1 min read
We support latest Emmerdale storyline on Faith Dingle's Secondary Breast Cancer diagnosis 17 May 2022 1 min read
We comment on saliva samples used to determine breast cancer risk in women of screening age 23 May 2022 1 min read
